Zobrazeno 1 - 10
of 98
pro vyhledávání: '"C, Giambi"'
Publikováno v:
Annali di igiene : medicina preventiva e di comunita. 34(1)
Understanding the level of awareness in adolescents on the value of vaccination is kay to developing a proper culture of prevention to counter vaccine hesitancy and the decrease in vaccination coverages.The aim of the survey was to evaluate awareness
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C Giambi, A Filia, M C Rota, M Del Manso, S Declich, G Nacca, E Rizzuto, A Bella, Collective regional contact points for rubella
Publikováno v:
Eurosurveillance. 20
In accordance with the goal of the World Health Organization Regional Office for Europe, the Italian national measles and rubella elimination plan aims to reduce the incidence of congenital rubella cases to?less than?one case per 100,000 live births
Autor:
J Mereckiene, S Cotter, A Nicoll, P Lopalco, T Noori, J T Weber, F D'Ancona, D Lévy-Bruhl, L Dematte, C Giambi, P Valentiner-Branth, I Stankiewicz, E Appelgren, D O’Flanagan, Collective the VENICE project gatekeepers group
Publikováno v:
Eurosurveillance. 19
Since 2008, annual surveys of influenza vaccination policies, practices and coverage have been undertaken in 29 European Union (EU)/ European Economic Area (EEA) countries. After 2009, this monitored the impact of European Council recommendation to i
Autor:
M. C. Rota, A. Bella, G. Gabutti, C. Giambi, A. Filia, P. Crovari, M. l. Ciofi degli Atti, on the behalf of the Serological study Group, GUIDO, Marcello, DE DONNO, Maria Antonella
The objective of this study is to evaluate how increasing MMR infant vaccination coverage in recent years has modified the epidemiology of rubella in Italy. A cross-sectional population-based seroprevalence study of rubella antibodies was conducted o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4034::dd06a11dd0e0f479b8b938f82b1257d1
https://hdl.handle.net/11587/300252
https://hdl.handle.net/11587/300252
Autor:
J Mereckiene, S Cotter, J T Weber, A Nicoll, F D'Ancona, P L Lopalco, K Johansen, A M Wasley, P Jorgensen, D Lévy-Bruhl, C Giambi, P Stefanoff, L Dematte, D O’Flanagan, Collective the VENICE project gatekeepers group
Publikováno v:
Europe PubMed Central
In August 2010 the Vaccine European New Integrated Collaboration Effort (VENICE) project conducted a survey to collect information on influenza A(H1N1)pdm09 vaccination policies and vaccination coverage in the European Union (EU), Norway and Iceland.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1458fa131fa5601db96c34c0b018c77
http://hdl.handle.net/11568/800002
http://hdl.handle.net/11568/800002
Autor:
J Mereckiene, S Cotter, F D'Ancona, C Giambi, A Nicoll, D Lévy-Bruhl, P L Lopalco, J T Weber, K Johansen, L Dematte, S Salmaso, P Stefanoff, D Greco, F Dorleans, A Polkowska, D O’Flanagan, null on behalf of the VENICE project gatekeepers group
Publikováno v:
Scopus-Elsevier
Fortunato D'Ancona
Europe PubMed Central
Fortunato D'Ancona
Europe PubMed Central
In 2009 the second cross-sectional web-based survey was undertaken by the Vaccine European New Integrated Collaboration Effort (VENICE) project across 27 European Union (EU) member states (MS), Norway and Iceland (n=29) to determine changes in offici
Autor:
C, Giambi, M C, Rota, A, Bella, A, Filia, G, Gabutti, M, Guido, A, De Donno, M L, Ciofi degli Atti
Publikováno v:
Annali di igiene : medicina preventiva e di comunita. 19(2)
In November 2003 the National Plan for the elimination of measles and congenital rubella was approved, with the aim of reducing and maintaining the incidence of congenital rubella syndrome (CRS) at less than 1 case per 100,000 live births by 2007. In
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Minerva endocrinologica. 27(2)
The aim of the study was evaluate the short and long-term effects of growth hormone therapy in subjects affected by Trisomy 21.The growth curves of 10 Down's syndrome patients (3 males and 7 females) aged between 21 and 35 years old were analysed. Du